FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$2.5B
1-Year Return
52.94%
This Quarter Return
+10.82%
1 Year Return
+52.94%
3 Year Return
+530.54%
5 Year Return
–
10 Year Return
–
AUM
$2.5B
AUM Growth
+$313M
(+14%)
Cap. Flow
+$160M
Cap. Flow
% of AUM
6.41%
Top 10 Holdings %
Top 10 Hldgs %
67.82%
Holding
55
New
8
Increased
16
Reduced
5
Closed
6
Top Buys
| 1 |
Zai Lab
ZLAB
|
$33.5M |
| 2 |
Aura Biosciences
AURA
|
$31.9M |
| 3 |
Phathom Pharmaceuticals
PHAT
|
$22.6M |
| 4 |
Evolus
EOLS
|
$22.4M |
| 5 |
Akero Therapeutics
AKRO
|
$19.6M |
Top Sells
| 1 |
Rhythm Pharmaceuticals
RYTM
|
$36M |
| 2 |
Soleno Therapeutics
SLNO
|
$35.7M |
| 3 |
Merus
MRUS
|
$15.7M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$7.81M |
| 5 |
Rocket Pharmaceuticals
RCKT
|
$7.2M |
Sector Composition
| 1 | Healthcare | 99.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Immatics
IMTX
$688M
| – | – |
-1,247,911
| Closed | -$5.63M |
|
|
52
Merus
MRUS
$4.99B
| – | – |
-373,100
| Closed | -$15.7M |
|
|
53
Rocket Pharmaceuticals
RCKT
$346M
| – | – |
-1,079,025
| Closed | -$7.2M |
|
|
54
Rhythm Pharmaceuticals
RYTM
$6.89B
| – | – |
-678,760
| Closed | -$36M |
|
|
55
Soleno Therapeutics
SLNO
$3.71B
| – | – |
-499,159
| Closed | -$35.7M |
|